Table 1.
Characteristic | Sleep ≥7 hours (n = 364) | Sleep <7 hours (n = 378) | P |
---|---|---|---|
Demographics | |||
Age, y | 64.62 (11.03) | 62.34 (11.60) | .006 |
Female, No. (%) | 110 (30.2) | 142 (37.6) | .04 |
Educational level, y | 13.24 (4.36) | 13.20 (4.17) | .91 |
Black, No. (%) | 73 (20.1) | 91 (24.1) | .19 |
Clinical Severity | |||
Charlson comorbidity index | 1.70 (1.69) | 1.58 (1.65) | .35 |
GRACE | 93.78 (29.09) | 89.39 (30.17) | .04 |
LVEF <40%, No. (%) | 49 (13.5) | 47 (12.4) | .68 |
Behavioral, Psychosocial, and Sleep Factors | |||
Body mass index | 28.92 (5.56) | 29.61 (5.86) | .10 |
Depressive symptoms | 7.33 (6.78) | 9.65 (7.11) | <.001 |
Past-month sleep medication use, No. (%) | 53 (14.6) | 90 (23.9) | .001 |
Past-month breathing-related sleep disturbance, No. (%) | 46 (12.7) | 91 (24.2) | <.001 |
Outcome | |||
ACS recurrence or death, No. (%) | 51 (14.0) | 76 (20.1) | .03 |
Days to ACS recurrence or death | 351.11 (96.89) | 339.08 (107.77) | .11 |
Abbreviations: ACS, acute coronary syndrome; GRACE, Global Registry of Coronary Events; LVEF, left ventricular ejection fraction; PULSE, Prescription Use, Lifestyle, and Stress Evaluation study.
Data are presented as mean (SD) unless otherwise indicated. Sleep duration was assessed at baseline. ACS recurrence includes hospitalization for nonfatal MI or unstable angina.